A n injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published in ...

Medically reviewed by Daniel More, MD Medications that target inflammation, such as immunotherapy and steroids, treat allergic asthma, a common type of asthma. Identifying triggers and avoiding ...

Typically, Nucala is given once every 4 weeks as a subcutaneous injection. Nucala (mepolizumab) is indicated for the treatment of severe asthma and other conditions related to high levels of ...

In less than 30 days, on April 15, Blue Cross Blue Shield Texas will begin updating its policies that shift certain asthma ...

In all, 36% of children treated with omalizumab (Xolair) for a year successfully ate full servings of allergy-triggering foods, according to phase 2 trial results. Adobe stock/HealthDay ...

Given by injection every four weeks, the drug offers an extra option for patients with the most severe symptoms, including those who suffer multiple asthma attacks. In April, NICE’s appraisal ...

is changing how certain asthma injections are administered. Effective April 15, 2025, some patients will need to self-administer asthma medications at home rather than receiving them at a clinic.

People with severe asthma insured by BlueCross BlueShield of Illinois may soon face a new hurdle in accessing a treatment ...

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...

Dr. Atkinson treats asthma patients. Most of them use an inhaler, but a small number need a shot, likely from medications such as Fasenra (benralizumab), Tezspire (tezepelumab), Nucala ...